149 related articles for article (PubMed ID: 4661662)
1. Haemolytic effects of DDS in leprosy patients.
Khaire DS; Magar NG
Indian J Med Res; 1972 Oct; 60(10):1510-9. PubMed ID: 4661662
[No Abstract] [Full Text] [Related]
2. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
Deps P; Guerra P; Nasser S; Simon M
Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
[TBL] [Abstract][Full Text] [Related]
3. Dapsone haemolysis in leprosy. A preliminary report.
Menezes S; Rege VL; Sehgal VN
Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
[TBL] [Abstract][Full Text] [Related]
4. Is dapsone safe?
Pettit JH
Int J Dermatol; 1981 Mar; 20(2):106-7. PubMed ID: 7216589
[No Abstract] [Full Text] [Related]
5. The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (DDS).
Powell RD; DeGowin RL; Eppes RB; McNamara JV; Carson PE
Int J Lepr Other Mycobact Dis; 1967; 35(4):590-604. PubMed ID: 4869693
[No Abstract] [Full Text] [Related]
6. Treatment of leprosy.
Kulkarni AG
Natl Med J India; 1992; 5(2):96. PubMed ID: 1304277
[No Abstract] [Full Text] [Related]
7. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Mysore V; al-Suwaid AR
Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
[No Abstract] [Full Text] [Related]
8. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
Ranawaka RR; Mendis S; Weerakoon HS
Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
[TBL] [Abstract][Full Text] [Related]
9. [Ulcer on white atrophy: hemolytic anemia caused by disulone revealing an erythrocytic glutathione reductase deficiency].
Dugois P; Amblard P; Léger J; Pinguet JP
Bull Soc Fr Dermatol Syphiligr; 1972; 79(2):199-200. PubMed ID: 4657112
[No Abstract] [Full Text] [Related]
10. [Erythrocyte enzymes and drugs].
Löhr GW; Arnold H; Blume KG
Haematol Blood Transfus; 1978; 21():215-24. PubMed ID: 367895
[No Abstract] [Full Text] [Related]
11. NADH-methemoglobin reductase and methemoglobinemia among leprosy patients.
Magna LA; Beiguelman B
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):475-81. PubMed ID: 6535820
[TBL] [Abstract][Full Text] [Related]
12. [Drug hazards related to hereditary constitution. Hematological accidents].
Barge A; Dausset J
Rev Immunol (Paris); 1971; 35(3):121-32. PubMed ID: 5130851
[No Abstract] [Full Text] [Related]
13. Study of erythrocyte G6PD deficiency in leprosy.
Banait PP; Junnarkar RV
Int J Lepr Other Mycobact Dis; 1971; 39(2):168-71. PubMed ID: 5167841
[No Abstract] [Full Text] [Related]
14. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
[TBL] [Abstract][Full Text] [Related]
15. Effect of dapsone on haemoglobin concentration in patients with leprosy.
Byrd SR; Gelber RH
Lepr Rev; 1991 Jun; 62(2):171-8. PubMed ID: 1870379
[TBL] [Abstract][Full Text] [Related]
16. Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage.
Manfredi G; De Panfilis G; Zampetti M; Allegra F
Br J Dermatol; 1979 Apr; 100(4):427-32. PubMed ID: 454569
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced hemolytic anemia.
Beutler E
Pharmacol Rev; 1969 Mar; 21(1):73-103. PubMed ID: 4887725
[No Abstract] [Full Text] [Related]
18. Dapsone-induced methemoglobinemia in leprosy patients.
Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
[No Abstract] [Full Text] [Related]
19. [Erythrocyte glucosephosphate dehydrogenase deficiency as a factor in a drug-induced hemolytic crisis in a patient of Asiatic origin].
Jabłońska-Skwiecińska E; Przybylska-Dargiewicz Z; Sawicka B; Pertkiewicz M
Pol Tyg Lek; 1983 Sep; 38(38):1181-4. PubMed ID: 6672800
[No Abstract] [Full Text] [Related]
20. [Systematic detection at birth of drug-induced hemolytic anemia caused by a toxic mechanism linked to an erythrocyte deficiency of glucose-6-phosphate dehydrogenase].
Collombel C; Kissen C; Dorche C; Baltassat P; Cotte J
Eur J Toxicol; 1970; 3(1):42-8. PubMed ID: 5520461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
